Sorbitol Liquid (E420(ii)) CAS: 50-70-4
Insights relacionados
Acrylonitrile Data Reversal: What a 520,000-Tonne Reporting Swing Means for Chemical Procurement
A reported 520,000-tonne acrylonitrile data reversal in early July 2026 highlights how production statistics can change rapidly and influence market expectations. Procurement teams should understand why reliable market intelligence is just as important as pricing when making sourcing decisions.
Steam Cracker Economics: How China's High Utilization Is Squeezing European Petrochemical Producers
Chinese steam crackers operating near maximum capacity can spread fixed costs across larger output volumes and export surplus petrochemicals into global markets. European crackers averaging around 75% utilization face a widening cost disadvantage that could reshape polymer pricing, regional production and procurement strategies
Germany's Chemical Capacity Utilization Stuck at 75.1%: What VCI's Unprofitable Threshold Means for Buyers
German chemical capacity utilization improved slightly to 75.1% but remains below the level needed for profitable production. With VCI expecting output to fall again across 2026, procurement teams should prepare for restructuring, reduced local availability and greater import dependence.
Heparin Q3 Supply Intelligence: Porcine Season, Freight Cost Trends & Procurement Priorities
China’s summer porcine processing season is maintaining a healthy heparin supply, while freight costs are easing. Hospital pharmacies and procurement teams can now focus Q3 planning on logistics, documentation, and future supply trends. This guide outlines key priorities for a secure and cost‑effective heparin supply chain.
Drug Shortage Risk: H1 2026 Closing Assessment and H2 Procurement Priorities
Drug shortages remained a major concern throughout H1 2026 as geopolitical disruptions, concentrated API production, and emerging demand for GLP-1 manufacturing inputs reshaped pharmaceutical procurement strategies for H2.
India Duty Waiver Expiry: Pharmaceutical Packaging Input Cost Reset in July 2026
India's temporary customs duty waiver on key pharmaceutical packaging polymers expires, reshaping procurement costs for medical packaging manufacturers. Here's what pharmaceutical companies should expect in Q3 2026.
Não perca nossas atualizações! Assine nossa newsletter agora
Estamos comprometidos com sua privacidade. A Tradeasia usa as informações fornecidas para entrar em contato com você sobre conteúdos, produtos e serviços relevantes. Para mais informações, consulte nossa política de privacidade.